Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,177)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02357836 | Neoadjuvant Itraconazole in Non-small Cell Lung Cancer | completed | Early Phase 1 | 13 | University of Texas Southwestern Medical CenterOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT04753918 | Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study | unknown | Early Phase 1 | 3 | Taoyuan General HospitalOTHER_GOV | 0 | Feb 15, 2021 | clinicaltrials |
| NCT04489862 |
| αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors |
| unknown |
| Early Phase 1 |
| 10 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER |
| 1 |
| Jul 28, 2020 |
| clinicaltrials |
| NCT03224871 | UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC. | completed | Early Phase 1 | 3 | University of California, DavisOTHER | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03574220 | Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Apr 7, 2020 | clinicaltrials |
| NCT03371992 | Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC(NO3DEXPL) | unknown | Early Phase 1 | 25 | Nilogen OncosystemsINDUSTRY | 1 | Mar 27, 2020 | clinicaltrials |
| NCT01707823 | Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer | terminated | Early Phase 1 | 4 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT01413451 | Amatuximab for High Mesothelin Cancers | terminated | Early Phase 1 | 7 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT02628080 | Atovaquone as Tumour HypOxia Modifier(ATOM) | completed | Early Phase 1 | 46 | University of OxfordOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01666353 | PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy | completed | Early Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT02463994 | A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC | completed | Early Phase 1 | 12 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT01261299 | Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | terminated | Early Phase 1 | 21 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03060343 | Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) | unknown | Early Phase 1 | 10 | Yu FengleiOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02319889 | Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma | terminated | Early Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT02568033 | Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer | unknown | Early Phase 1 | 22 | The Cooper Health SystemOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT02419170 | Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 18, 2016 | clinicaltrials |
| NCT02277457 | Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01525446 | Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer | terminated | Early Phase 1 | 7 | Massachusetts General HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00221169 | Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer | completed | Early Phase 1 | 31 | Toronto Sunnybrook Regional Cancer CentreOTHER | 1 | Feb 5, 2009 | clinicaltrials |
Data updated 23 days agoSource updated May 3, 2021source: clinicaltrials